Evidence map›Paper›PMID 42902136›Full record

ArticleBMC cardiovascular disorders2026

Relationship between hyperuricemia and cardiovascular risk among postmenopausal women in cameroon: a community-based study.

Stéphane Fargeon Massin Mbouna, Jan René Nkeck, Néri Ngole Atabe, Stéphane Yves Mbana Bikoi, Raphael Kinyuy Ndze, Emeraude Sorelle Mbock, Jean Maximilien Tang, Danielle Cécile Tang-Likeng, Claude Cyrille Ndoua Noa, Vicky Jocelyne Ama-Moor

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stéphane Fargeon Massin MbounaClinical Research Department, PRIMA SARL Laboratory, Yaoundé, Cameroon. mstephanefargeon@gmail.com.ORCID http://orcid.org/0000-0003-0286-1499
Jan René NkeckRheumatology Department, Central Hospital of Yaoundé, Yaoundé, Cameroon.
Néri Ngole AtabePublic Health Department, Bora Africa Research Academy, Yaoundé, Cameroon.
Stéphane Yves Mbana BikoiPublic Health Department, Bora Africa Research Academy, Yaoundé, Cameroon.
Raphael Kinyuy NdzeClinical Research Department, PRIMA SARL Laboratory, Yaoundé, Cameroon.
Emeraude Sorelle MbockClinical Research Department, PRIMA SARL Laboratory, Yaoundé, Cameroon.
Jean Maximilien TangClinical Research Department, PRIMA SARL Laboratory, Yaoundé, Cameroon.
Danielle Cécile Tang-LikengClinical Research Department, PRIMA SARL Laboratory, Yaoundé, Cameroon.
Claude Cyrille Ndoua NoaObstetrics and Gynaecology Department, Hospital Centre for Endoscopic Surgery and Human Reproduction, Yaoundé, Cameroon.
Vicky Jocelyne Ama-MoorDepartment of Clinical Biochemistry, Faculty of Medicine and Biomedical Sciences, University Teaching Hospital of Yaoundé, University of Yaoundé I, Yaoundé, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDespite the known association between hyperuricemia and an increased risk of cardiovascular disease, the prevalence and epidemiology of hyperuricemia in postmenopausal women in Cameroon are not yet fully understood. This study aimed to evaluate the prevalence of hyperuricemia, identify its associated factors, and examine its association with cardiovascular risk markers among postmenopausal women living in Yaoundé.

methodsA cross-sectional study was conducted in Yaoundé from November 2024 to June 2025, involving 206 postmenopausal women. Biological measurements were performed at PRIMA Lab using the Cobas 6000

resultsOut of 206 postmenopausal women, the mean age was 63.5 ± 8.7 [48-87] years. The prevalence of hyperuricemia was 37.9%. Menopausal duration ≥ 14 years (OR = 2.8; P = 0.016), overweight/obesity (OR = 1.9; P = 0.030) and hypertension (OR = 2.0; P = 0.036). Hyperuricemia was significantly associated with non-HDL cholesterol ≥ 130 mg/dL (P = 0.001), LDL/HDL ratio (P = 0.001), WHO CVR score ≥ 10% (P = 0.018), and non-HDL/total cholesterol ratio (P = 0.045).

conclusionMore than one-third of postmenopausal women have been diagnosed with hyperuricemia. Long duration of menopause, overweight/obesity and hypertension were independently associated with hyperuricemia. Hyperuricemia was significantly associate with non-HDL cholesterol, LDL/HDL ratio, non-HDL/total cholesterol ratio and WHO CVR score.

Indexed as

Cardiovascular DiseasesHyperuricemiaPostmenopauseUric AcidAgedAged, 80 and overBiomarkersCameroonCross-Sectional StudiesFemaleHeart Disease Risk FactorsHumansMiddle AgedPrevalenceRisk AssessmentRisk FactorsBiomarkersUric AcidAsymptomatic hyperuricemiaCameroonCardiovascular riskPost-menopause

Identifiers

PMID42902136
PMCPMC13685349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.